Artemis Wealth Advisors, LLC Fate Therapeutics Inc Transaction History

Artemis Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$17.78 - $42.39 $1.78 Million - $4.24 Million	-100,000 Closed	0 $0
Q1 2022 Aug 21, 2023	BUY	$29.67 - $60.28 $2.97 Million - $6.03 Million	100,000 New	100,000 $3.88 Million
Q1 2022 Apr 22, 2022	BUY	$29.67 - $60.28 $2.97 Million - $6.03 Million	100,000 New	100,000 $3.88 Million
Q1 2021 Sep 11, 2023	BUY	$72.16 - $117.4 $7.22 Million - $11.7 Million	100,000 New	100,000 $8.25 Million
Q4 2020 Sep 05, 2023	BUY	$38.09 - $100.95 $3.81 Million - $10.1 Million	100,000 New	100,000 $9.09 Million
Q4 2020 Feb 17, 2023	BUY	$38.09 - $100.95 $3.81 Million - $10.1 Million	100,000 New	100,000 $9.09 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.